Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content + Download Section PDF Listen ++ For further information, see CMDT Part 21-17: Metabolic Acidosis + Download Section PDF Listen ++ For further information, see CMDT Part 21-18: Increased Anion Gap Acidosis (Increased Unmeasured Anions) + Key Features Download Section PDF Listen +++ +++ Essentials of Diagnosis ++ Hallmark of this disorder is that metabolic acidosis (thus low HCO3–) is associated with normal serum Cl–, so that the anion gap increases Decreased HCO3– is also seen also in respiratory alkalosis, but pH distinguishes between the two disorders +++ General Considerations ++ Calculation of the anion gap is useful in determining the cause of the metabolic acidosis Normochloremic (increased anion gap) metabolic acidosis Generally results from addition to the blood of organic acids such as lactate, acetoacetate, β-hydroxybutyrate, and exogenous toxins Uremia produces an increased anion gap metabolic acidosis via unexcreted organic acids and anions +++ Etiology ++ Lactic acidosis Type A: cardiogenic, septic, or hemorrhagic shock; carbon monoxide or cyanide poisoning Type B: metabolic causes (eg, diabetes mellitus, ketoacidosis, liver disease, kidney disease, infection, leukemia, or lymphoma); toxins (eg, ethanol, methanol, salicylates, isoniazid, or metformin); nucleoside analog reverse transcriptase inhibitors Diabetic ketoacidosis Alcoholic ketoacidosis Acid-base disorders in alcoholism are frequently mixed (10% have triple acid-base disorder) Three types of metabolic acidoses: ketoacidosis, lactic acidosis, and hyperchloremic acidosis from bicarbonate loss in urine from ketonuria Metabolic alkalosis from volume contraction and vomiting Respiratory alkalosis from alcohol withdrawal, pain, sepsis, or liver disease Uremic acidosis (usually at glomerular filtration rate < 15–30 mL/min) Ethylene glycol toxicity Methanol toxicity Salicylate toxicity (mixed metabolic acidosis with respiratory alkalosis) + Clinical Findings Download Section PDF Listen +++ +++ Symptoms and Signs ++ Symptoms are mainly those of the underlying disorder Compensatory hyperventilation may be misinterpreted as a primary respiratory disorder When severe, Kussmaul respirations (deep, regular, sighing respirations indicating intense stimulation of the respiratory center) occur + Diagnosis Download Section PDF Listen +++ +++ Laboratory Tests ++ See Table 21–13 Blood pH, serum HCO3–, and PCO2 are decreased Anion gap is increased (normochloremic) Hyperkalemia may be seen In lactic acidosis, lactate levels are at least 4–5 mEq/L but commonly 10–30 mEq/L The diagnosis of alcoholic ketoacidosis is supported by the absence of a diabetic history and no evidence of glucose intolerance after initial therapy ++Table Graphic Jump LocationTable 21–13.Primary acid-base disorders and expected compensation.View Table||Download (.pdf)Table 21–13. Primary acid-base disorders and expected compensation. Disorder Primary Defect Compensatory Response Magnitude of Compensation Respiratory acidosis Acute ↑ PCO2 ↑ HCO3– ↑ HCO3– 1 mEq/L per 10 mm Hg ↑ PCO2 Chronic ↑ PCO2 ↑ HCO3– ↑ HCO3– 3.5 mEq/L per 10 mm Hg ↑ PCO2 Respiratory alkalosis Acute ↓ PCO2 ↓ HCO3– ↓ HCO3– 2 mEq/L per 10 mm Hg ↓ PCO2 Chronic ↓ PCO2 ↓ HCO3– ↓ HCO3– 5 mEq/L per 10 mm Hg ↓ PCO2 Metabolic acidosis ↓ HCO3– ↓ PCO2 ↓ PCO2 1.3 mm Hg per 1 mEq/L ↓ HCO3– Metabolic alkalosis ↑ HCO3– ↑ PCO2 ↑ PCO2 0.7 mm Hg per 1 mEq/L ↑ HCO3– + Treatment Download Section PDF Listen +++ +++ Medications ++ Supplemental HCO3– is indicated for treatment of hyperkalemia but is controversial for treatment of increased anion gap metabolic acidosis Administration of large amounts of HCO3 – may have deleterious effects, including Hypernatremia Hyperosmolality Volume overload Worsening of intracellular acidosis In salicylate intoxication, alkali therapy must be started unless blood pH is already alkalinized by respiratory alkalosis, because the increment in pH converts salicylate to more impermeable salicylic acid and thus prevents CNS damage The amount of HCO3 – deficit can be calculated as follows: Amount of HCO3– deficit = 0.5 × body weight × (24 – HCO3–) Half of the calculated deficit should be administered within the first 3–4 h to avoid overcorrection and volume overload In methanol intoxication, ethanol is administered as a competitive substrate for alcohol dehydrogenase, the enzyme that metabolizes methanol to formaldehyde Inhibition of alcohol dehydrogenase by fomepizole is the standard of care +++ Therapeutic Procedures ++ Treatment is aimed at the underlying disorder, such as insulin and volume resuscitation to restore tissue perfusion Lactate will later be metabolized to produce HCO3– and increase pH + Outcome Download Section PDF Listen +++ +++ Prognosis ++ The mortality rate of lactic acidosis exceeds 50% +++ Prevention ++ Avoid metformin use if there is tissue hypoxia or acute kidney injury Acute kidney injury can occur rarely with the use of radiocontrast agents in patients receiving metformin therapy Metformin should be temporarily halted on the day of the test and for 2 days after injection of radiocontrast agents to avoid potential lactic acidosis if renal failure occurs +++ When to Admit ++ Because of the high mortality rate, all patients with lactic acidosis should be admitted Other patients with significant metabolic acidosis are almost always admitted, particularly those resulting from diabetic ketoacidosis, alcoholic ketoacidosis, uremic acidosis, or ethylene glycol, methanol toxicity or salicylate toxicity + References Download Section PDF Listen +++ + +Fayfman M et al. Management of hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Med Clin North Am. 2017 May;101(3):587–606. [PubMed: 28372715] + +Lalau JD et al. Metformin-associated lactic acidosis (MALA): moving towards a new paradigm. Diabetes Obes Metab. 2017 Nov;19(11):1502–12. [PubMed: 28417525] + +Palmer BF et al. Electrolyte and acid-base disturbances in patients with diabetes mellitus. N Engl J Med. 2015 Aug 6;373(6):548–59. [PubMed: 26244308] + +Seheult J et al. Lactic acidosis: an update. Clin Chem Lab Med. 2017 Mar 1;55(3):322–33. [PubMed: 27522622] + +Sharma S et al. Comprehensive clinical approach to renal tubular acidosis. Clin Exp Nephrol. 2015 Aug;19(4):556–61. [PubMed: 25951806] + +Suetrong B et al. Lactic acidosis in sepsis: it's not all anaerobic: implications for diagnosis and management. Chest. 2016 Jan;149(1):252–61. [PubMed: 26378980]